WO1988006896A1 - Apparatus and method for admixture blood warming - Google Patents

Apparatus and method for admixture blood warming Download PDF

Info

Publication number
WO1988006896A1
WO1988006896A1 PCT/US1988/000255 US8800255W WO8806896A1 WO 1988006896 A1 WO1988006896 A1 WO 1988006896A1 US 8800255 W US8800255 W US 8800255W WO 8806896 A1 WO8806896 A1 WO 8806896A1
Authority
WO
WIPO (PCT)
Prior art keywords
container
saline solution
temperature
blood
set forth
Prior art date
Application number
PCT/US1988/000255
Other languages
French (fr)
Inventor
Ethan B. Wilson
Original Assignee
Minnesota Mining And Manufacturing Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining And Manufacturing Company filed Critical Minnesota Mining And Manufacturing Company
Publication of WO1988006896A1 publication Critical patent/WO1988006896A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
    • A61M5/445Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media the media being heated in the reservoir, e.g. warming bloodbags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • A61M2205/3626General characteristics of the apparatus related to heating or cooling by controlled mixing of fluids at different temperatures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/155Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by gas introduced into the reservoir

Definitions

  • the present invention relates to blood warming apparatus and, more particularly, to apparatus for mechanically and rapidly admixing blood products at a storage temperature with a heated saline solution to produce a transfusable mixture without significant hemolysis at a rate commensurate with transfusion equipme and at a temperature within an acceptable range to avoid hypothermia.
  • the apparatus for warming includes a container for blood products retrieved from cold storage and at a temperature of 4-10°C.
  • Apparatus for rapidly discharging the blood product from its container is associated with the container.
  • the apparatus also supports a further container for a saline solution at a temperature in the range of 50° to less than 80°C.
  • Apparatus for rapidly evacuating the saline solution from its container is associated with the container.
  • a conduit extends from each of the blood products container and the saline solution container to a junction wherefrom a further conduit conveys a mixture of the fluids to transfusion related equipment.
  • the saline solution can be expressed from its container through the conduit into the blood products container.
  • Apparatus acting upon the blood products container during inflow of the saline solution will force rapid mechanical admixing with the blood products.
  • the resulting mixture being at temperature within the range suitable for transfusion and without hemolysis due to the rapid mixing, may be injected through conventional transfusion apparatus.
  • the contents of the two containers can be expressed simultaneously.
  • a rapid admixing of the blood products and the saline solution will occur due to the intersection of the two resulting streams of fluid at the junction of the conduits.
  • the admixing will raise the temperature of the mixture to a range sufficient to preve hypothermia and without causing hemolysis.
  • Still another object of the present invention i to provide apparatus for rapidly warming erythrocytes without creating a danger of hemolysis.
  • Still another object of the present invention i to provide apparatus for warming blood products commensurate with the flow rate of available transfusion equipment.
  • a further object of the present invention is to provide a method for rapidly warming erythrocytes.
  • a yet further object of the present invention i to provide a method for admixing chilled blood products a heated saline solution at a rate commensurate with transfusion equipment without danger of hemolysis.
  • a still further object of the present invention is to provide a method for mechanically mixing blood products with a heated saline solution to rapidly raise t temperature of the blood products.
  • Figures 1-3 are graphs depicting osmotic fragility
  • Figure 4 is a perspective view of an embodiment of the present invention.
  • Figures 5a and 5b illustrate flow directions during each of two phases of operation of the present invention;
  • Figure 6 illustrates the flow direction during a further operation of the present invention
  • Figure 7 is a perspective view of a variant of the present invention.
  • Figure 8 is a partial view of a variant for expressing a fluid.
  • the gist of the present invention which represents a major departure from previous blood warming apparatus and research is the concept that erythrocytes tolerate rapid admixture with a saline solution at temperatures in excess of 45°C. This is true despite the fact that the erythrocytes do not tolerate prolonged incubation at temperatures exceeding 45°C.
  • the admixture process with its rapid equilibration at an intermediate temperature, does not result in prolonged erythrocyte exposure to elevated temperatures. As a result, the erythrocytes can be rapidly warmed without hemolyzing.
  • an experiment was conceived and the results analyzed. In the experiment, plasma hemoglobin concentrations were utilized as an indicator of erythrocyte trauma.
  • Plasma hemoglobin also called free hemoglo in, has been utilized for this purpose in most blood warming studies. These studies have presumed, and clinical experience in blood transfusion has supported, th concept that the most labile component of an erythrocyte i its membrane rather than the hemoglobin. Presumably, if the erythrocyte membrane integrity is maintained, then the enclosed hemoglobin will be functional.
  • Clinical application of blood warming wi h the present invention would require the availability of heated containers of normal saline solution.
  • Methods for heating saline solution containers include microwave ovens or dry oven/incubator. While use of microwave ovens to warm saline solution is an acceptable method, it introduces an additional time delay prior to beginning transfusion. Owing to changes in saline concentration over time, long term water bath incubation is not recommended by at least certain of the manufacturers of the saline solution. Blanket warmers to not offer close enough temperature requlation (+/- 5.5°C) to be acceptable for application. At present, the most acceptable instrument for saline solution heating and storage is a microbiological incubator. This type of unit provides close temperature regulation (+/- 0.5°C) and is able to achieve the temperatures utilized herein.
  • the materials for admixture blood warming are already used in transfusion therapy. These include saline solution bags, large bore transfusion sets, Y-type transfusion sets and plasma transfer sets.
  • pressure can be applied by hand or by using a standard pressure cuff.
  • Optimal control of the mixture temperature will be obtained by ensuring a 1:1 saline/erythrocyte mixture. This may necessitate either standardization of erythrocyt volumes or weighing of individual units and admixing with an equal amount of heated saline solution.
  • Assessment of mixture temperature can be achieved using external temperature sensors.
  • Units of red blood cells were prepared from blo collected in citrate-phosphate-dextrose-adenine solution (CPDA-1) and stored in standard blood containers at 4°C until used. The average hematocrit of these units was 75 At the time of the admixture tests, the units were divide into paired aliquotes of 100 to 125 g. each. All admixtu tests and controls were done on day 35 following blood donation. For admixture tests, saline solution bags (suc as travenol 0.9% NaCl ) were weighted to within one gram o the erythrocyte aliquotes (100 to 125 g.). The saline solution bags were then water bath heated to either 60, 7 or 80°C.
  • CPDA-1 citrate-phosphate-dextrose-adenine solution
  • Temperature was determined using an in-bag prob (such as Hewlett-Packard #2802A) . Bags of erythrocytes, 6-10°C were gently agitated by hand while heated saline w rapidly added under hand-generated pressure via a plasma transfer set. This was accomplished by squeezing the saline solution bag with a gloved hand. Agitation consisted of a rapid (once per second) rocking of the blo bag. Saline was transferred within 15 seconds; agitation continued for 1 minute. The mixture temperature was measured by a probe in the bag and samples were obtained for osmotic fragility tests. The mixture was then centrifuged and the resultant supernatant assessed for plasma hemoglobin. Five trials were carried out at each temperature with a control for each trial and a total of 15 units of blood were used.
  • the controls consisted of an in-bag admixture of 100-125 g. aliquotes of erythrocytes (at 6-10°C) with a equal amount of cold saline (at 6-10°C). Osmotic fragilit of the resultant mixture was determined utilizing incubation in ten concentrations of NaCl (0-0.85%) followed by centrifrigation (lOOOg for 10 minutes) and colormetric reading at 540 nm. Plasma hemoglobin concentrations were determined following centrifugation of the admixture product (1000 g for 10 minutes). Colormetric absorption o the supernatant was assessed at 560, 575 and 590 nm. The technique was standardized using known concentrations of hemoglobin. The mean temperatures of the resultant erythrocyte—saline mixtures for the five trials at each of the saline temperatures (60, 70 and 80°C) were 30.9, 37.5 and 42.6°C, respectively.
  • Table 1 shows the Plasma hemoglobin and potassium values for control and admixture trials.
  • Figures 1 to 3 show average osmotic fragility curves for controls and admixture trials at each of the three saline solution temperatures. No significant difference was found between control and trials at any concentration of NaCl (0-0.85%) for saline solution temperatures of 60°C and 70°C. Trials using 80° saline solution resulted in significantly increased osmotic fragility at multiple levels of NaCl concentration (p ⁇ .01, paired t-test).
  • a blood warmer device 10 for effecting a rapid mechanical mixing o blood products in a container 12 at storage temperature (4°C) with a heated saline solution in container 14.
  • Container 12 may be of the standard bag type used in the industry for collecting and storing erythrocytes (red blood cells). It may be suspended from suitably configured hook 16 supported by sidewall 18.
  • the container includes a discharge tube 20 extending from the lower end in penetrable engagement with a base 22.
  • Flow control means 24 regulates the flow through tube 20.
  • Container 14 may be an industry standard bag type for saline solution. Container 14 is suspended by a hook 30 supported by sidewall 32.
  • Container 14 also includes a tube 34 for discharging fluid out of the container and flo control means 36 regulates the flow through the tube.
  • a discharge conduit 40 is in fluid communication with tubes 20, 34 through a multi-port valve 42, which valve can accommodate flow between tubes 20 and 34 or between tube 34 and conduit 40 through manipulation of a pointer/knob 44, which may be substituted by semi-automatic or automatic flow control/regulation devices.
  • a flow control means 46 regulates flow through conduit 40. It is to be understood that any or all of flow control means 24, 36 and 46 may include any type of functionally related devices, such as centrifugal or roller pump assemblies for drawing or forcing fluid flow.
  • a partition 50 extends upwardly from base 22 for supporting means for expressing fluid from container 14 and for independently or simultaneously expressing fluid from container 12. Means for rapidly mechanically agitating the contents of container 12 may also be supported upon partition 50.
  • air bags such as air bags 52, 54, are supported upon partition 50 adjacent container 12.
  • a source of air under pressure, including pressure regulating means, (not illustrated) is connected to inlet conduit 56 of air bag 52 and inlet conduit 58 of air bag 54.
  • pressure regulating means (not illustrated) is connected to inlet conduit 56 of air bag 52 and inlet conduit 58 of air bag 54.
  • Control means may be employed to sequentially inflate/deflate air bags 52, 54 to urge rapid movement of the liquid within container 12 in response to the alternating locations of application of pressure.
  • Partition 50 may also be employed to support a pair of air bags 60, 62 adjacent container 14.
  • a source of air pressure and pressure regulating means (not illustrated) may be employed to regulate air flow into and out of the air bags through inlet conduits 64, 66. Expansion through inflation of either or both air bags 60, 62 will exert pressure against container 14 to urge expressing of any fluid contained therein through tube 34. If air bags 60, 62 are alternatively inflated/deflated, the resulting alternating pressure forces acting upon container 14 will have the effect of repetitively relocating the fluid within container 14. Such relocation will agitate the fluid and produce rapid mixing if the fluid is not already homogenous in content or temperature. Referring jointly to Figures 4, 5a, 5b and 6, t operation of blood warmer device 10 will be described.
  • Container 14 containing heated saline solution to be mix with blood products and to be infused by transfusion and a temperature in the range of 50 to less than 80°C, is suspended from hook 30 adjacent sidewall 32.
  • the admixture in container 14 is discharged therefrom through' tube 20 and multi port valve 42 after knob 40 has been turned to provide flow into conduit 40, a depicted in Figure 5b.
  • the flow through conduit 40 may be regulated by flow control means 46.
  • the admixture flows to and is injected by conventional transfusion equipment. From the above-description, it will be evident that air bags 52, 54 impose mechanical forces upon container 14 to agitate rapidly any fluid within the container, which agitation results in mixing of any fluids therein.
  • the degree of force to be applied and hence severity of agitation is a function of the pressures exerted by the air bags.
  • Rapid mechanical mixing may also be effected by the present invention through multi port valve 42.
  • valve 42 depicted in Figure 6 flow from each of tubes 20, 34 into conduit 40 is possible.
  • an admixing of the fluids will occur. Through such admixing, a temperature equilibrium of the admixture will come about relatively rapidly upon flow of the admixture into conduit 40.
  • the force exerted by the fluids upon one another at intersection 70 will be a function of the completeness of the admixture.
  • intersection 70 will be sufficiently brief to preclude incubation of any blood products at a temperature higher than 45°C for any significant time period if the initial temperature of the blood products is 4-10°C and the temperature of the saline solution is 50°C to less than 80°C. It is to be understood that the above described function of intersection 70 could be accomplished by a mixing chamber of simple or complex design and capability.
  • Figure 7 illustrates a variant 80 of blood warmer device 10 illustrated in Figure 4.
  • the flexible container for saline solution shown in Figure 4 has been replaced 'with a rigid sleeve and piston unit 82.
  • a bottom 84 extends across sleeve 86 to develop a containe for retaining a fluid, such as a saline solution to be expressed.
  • Conduit 34 extends into bottom 84 and is in fluid communication with the contents of the unit.
  • a translatable piston 88 is actuatable by a connecting rod plunger 90 bearing against a receiving cup 92.
  • a plurali of linkages and pivot mechanisms as depicted by numerals 94, 96, respectively, provide rectilinear translation to the plunger.
  • closed compartment 98 may be employ to house motive means for translating plunger 90 through linkages 94, 96.
  • Other means for imparting translatory movement to piston 88 may also be employed.
  • the sleeve and piston unit depicted in Figure 7 illustrates the unit to be essentially rectangular in cro section. Under certain circumstances, such configuration may not be preferred. Accordingly, a more conventional cylindrical sleeve and piston unit 100 is depicted in Figure 8.
  • sleeve 102 is terminated at its lower end by a bottom 104 having tube 112 connected thereto to convey a fluid expressed from the unit.
  • a disc like pist 106 is in sealed engagement with the interior surface wit sleeve 102 through 0-ring 108, or the like.
  • a rod 110 connected to a source of power (not illustrated) imparts a downward force upon the piston, which downward force discharges the fluid from within the compartment defined b piston 106 and sleeve 102 through tube 112.
  • sidewall 32 and partition 50 can be modified to receive and retain unit 100 and that th latter is capable of functioning in the manner of unit 82.
  • collapsible bags of saline solution can be placed within either of units 82, 100 to b expressed by force of the respective piston; means must be adapted to place discharge tube 34 in fluid communication with the bag.
  • a saline solution is housed as shown in Figur 4 or in either of sleeve and piston units 82, 100, sidewal 32 and partition 50 may be adapted to support heating elements for warming or for maintaining the temperature of the saline solution within the respective container.
  • Thes heating units are represented by dashed lines identified b reference numerals 114 and 116.
  • a heating unit 118 may be formed adjacent container 12 to maintain the contents of container 12 at or near body temperature. Appropriate heat/temperature limits may be incorporated in heating units 114, 116 and 118.
  • the respective saline container or sleeve and piston units may have a capacity equivalent to that of blood product container 12 with the admixture to be performed at valve 42 or in container 12.
  • container 14, units 82, 100 may each have a capacity which is a multiple of the capacity of container 12 to permit development of an admixture in each of several blood products containers before refill or replacement of container 14, units 82, 100.
  • the transfer from container 14, unit 82 or 100 to container 12 is the expressing of saline solution into the container.
  • Subsequent mixing within the container may be effected by alternate inflation/deflation of air bags 52, 54.
  • Final expression of the admixture fro container 12 may be effected through valve 42 into conduit 40. It is to be understood that other procedural variations may exist for effecting rapid, forced and mechanical mixing of the blood products and the saline solution.
  • the admixture within container 12 may be drawn into unit 82 through a combination of retraction of plunger 90 and inflation of air bags 52, 54 acting to compress container 12 while valv 42 is in the position depicted in Figure 5a.
  • the movement of plunger 90 may be reversed to force piston 88 to express the admixture through tubes 34 and 20 into container 12. This cycle may be repeated one or more times before the resulting admixture is discharged via valve 42 through conduit 40.

Abstract

Rapid mechanical admixing of blood products at a storage temperature of 4°C with a saline solution in a temperature range of 50-70°C results in a mixture temperature sufficient to prevent hypothermia upon transfusion, which temperature rise per volume of the blood products is at a rate commensurate with the flow rate of transfusion equipment while not exceeding the temperature tolerance of the erythrocytes.

Description

APPARATUS AND METHOD FOR ADMIXTURE BLOOD WARMING
Background of the Invention
1. Field of the Invention
The present invention relates to blood warming apparatus and, more particularly, to apparatus for mechanically and rapidly admixing blood products at a storage temperature with a heated saline solution to produce a transfusable mixture without significant hemolysis at a rate commensurate with transfusion equipme and at a temperature within an acceptable range to avoid hypothermia.
2. Related Prior Art
The management of massive blood loss resulting from trauma or surgery necessitates rapid transfusion capability. In order to avoid the deleterious effects of hypothermia, it is necessary to warm blood from its norma storage temperature of approximately 4°C prior to transfusion. Currently accepted blood warmers utilize passive heat transfer via dry warming panels or coils in water bath. These warmers cannot adequately warm blood a flow rates exceeding 500 ml/minute. This slow warming rat represents the rate-limiting step in rapid transfusion. Other methods of blood warming which have been suggested include microwave ovens, which are considered to cause unacceptable hemolysis; blood bag emersion which is slow and not completely clinically tested; and, an extracorporeal heat exchanger which utilizes expensive equipment and has not been completely clinically studied. Erythrocyte incubation studies have shown that prolonged exposure to temperatures greater than 48°C results in hemolysis and increased erythrocyte osmotic fragility. These results have been applied to the design of currently available blood warmers. Accordingly, heat source temperatures below 40°C are used which results in a slow transference of heat and dictates maximal blood warmer flow rates of less than 500 ml/minute. Because of these relatively low flow rates, blood warmer use in the emergent setting is often stopped just when a patient's transfusion requirement increases to the point where warming becomes most valuable. A typical state of the art blood warmer is sold under the trademark "INFUSER 37" by C.R. Bard, Inc. of Billerica Massachusetts. This blood warmer requires a heat exchanger wherein the heating water temperature is 40°C at a minimum flow rate of 10 1/minute.
Summary of the Invention The apparatus for warming includes a container for blood products retrieved from cold storage and at a temperature of 4-10°C. Apparatus for rapidly discharging the blood product from its container is associated with the container. The apparatus also supports a further container for a saline solution at a temperature in the range of 50° to less than 80°C. Apparatus for rapidly evacuating the saline solution from its container is associated with the container. A conduit extends from each of the blood products container and the saline solution container to a junction wherefrom a further conduit conveys a mixture of the fluids to transfusion related equipment. The saline solution can be expressed from its container through the conduit into the blood products container. Apparatus acting upon the blood products container during inflow of the saline solution will force rapid mechanical admixing with the blood products. The resulting mixture, being at temperature within the range suitable for transfusion and without hemolysis due to the rapid mixing, may be injected through conventional transfusion apparatus. In the alternative, the contents of the two containers can be expressed simultaneously. A rapid admixing of the blood products and the saline solution will occur due to the intersection of the two resulting streams of fluid at the junction of the conduits. The admixing will raise the temperature of the mixture to a range sufficient to preve hypothermia and without causing hemolysis. It is therefore a primary object of the present invention to provide rapid mechanical mixing of chilled blood products with a heated saline solution for transfusion without danger of hypothermia or hemolysis. Another object of the present invention is to provide apparatus for rapidly warming blood products to a temperature suitable for transfusion without danger of hypothermia.
Still another object of the present invention i to provide apparatus for rapidly warming erythrocytes without creating a danger of hemolysis.
Still another object of the present invention i to provide apparatus for warming blood products commensurate with the flow rate of available transfusion equipment. A further object of the present invention is to provide a method for rapidly warming erythrocytes.
A yet further object of the present invention i to provide a method for admixing chilled blood products a heated saline solution at a rate commensurate with transfusion equipment without danger of hemolysis.
A still further object of the present invention is to provide a method for mechanically mixing blood products with a heated saline solution to rapidly raise t temperature of the blood products. These and other objects of the present inventio will become apparent to those skilled in the art as the description thereof proceeds.
Brief Description of the Drawings The present invention may be described with greater clarity and specificity with reference to the drawings, in which: Figures 1-3 are graphs depicting osmotic fragility;
Figure 4, is a perspective view of an embodiment of the present invention; Figures 5a and 5b illustrate flow directions during each of two phases of operation of the present invention;
Figure 6 illustrates the flow direction during a further operation of the present invention; Figure 7, is a perspective view of a variant of the present invention; and
Figure 8 is a partial view of a variant for expressing a fluid.
Description of the Preferred Embodiment
The need for rapid transfusion arises frequently in emergency departments, at surgery and at critical care units. Prior to transfusion, however, blood products are stored at 4°C and require warming to avoid lowering core temperature. The cardiac dysrhythmia resulting from transfusion induced hypothermia have been well documented. For this reason, various methods of blood warming have bee developed utilizing external heat sources such as water baths, metal warming plates or microwave ovens. Problems arising from these blood warmers include slow flow rates, bulking and inconvenient equipment and damage to e yth ocytes. As a result of these difficulties, especially because of low flow rates, blood warmer use in the emergent setting is often suspended as the urgency of the patient's transfusion requirement increases. This disuse of blood warmers allows for the infusion of blood products at temperatures much below that which would be considered safe.
Erythrocyte incubation studies show that prolonged (greater than 15 minutes) exposure to temperatures over 45°C result in significant hemolysis. For this reason, commercial blood warmers utilize heat source temperatures below 40°C. This low temperature source tends to limit maximal blood warmer flow rates to 500 ml/minute or less due to the time needed for sufficie heat transference. When compared with available flow rat of over 1200 ml/minute for pressurized intravenous fluid administration sets incorporating large bore catheters, i becomes obvious that blood warmers represent a very significant rate limiting step in transfusion therapy.
One step common to all methods of blood warming for rapid transfusion is the dilution of erythrocytes pri to transfusion. This is necessary in order to optimize flow rates, given the high viscosity of undiluted erythrocytes. Admixture blood warming expands the utilit of this process by combining dilution and warming into on step. It results in warmed erythrocytes with a hematocri equal to that of whole blood.
The gist of the present invention which represents a major departure from previous blood warming apparatus and research is the concept that erythrocytes tolerate rapid admixture with a saline solution at temperatures in excess of 45°C. This is true despite the fact that the erythrocytes do not tolerate prolonged incubation at temperatures exceeding 45°C. The admixture process, with its rapid equilibration at an intermediate temperature, does not result in prolonged erythrocyte exposure to elevated temperatures. As a result, the erythrocytes can be rapidly warmed without hemolyzing. To verify this hypothesis, an experiment was conceived and the results analyzed. In the experiment, plasma hemoglobin concentrations were utilized as an indicator of erythrocyte trauma. The concentrations reflect the release of hemoglobin following erythrocyte membrane disruption. Plasma hemoglobin, also called free hemoglo in, has been utilized for this purpose in most blood warming studies. These studies have presumed, and clinical experience in blood transfusion has supported, th concept that the most labile component of an erythrocyte i its membrane rather than the hemoglobin. Presumably, if the erythrocyte membrane integrity is maintained, then the enclosed hemoglobin will be functional.
Comparing admixture blood warming with studies of other blood warming methods reveals similar levels of plasma hemoglobin in warmed samples. In no instance did plasma hemoglobin levels rise to a clinically important level, that is, to a level greater than that. hich could be cleared by the haptoglobinlymphoreticular system. Adults are able to clear up to five grams of free hemoglobin before beginning to develop hemoglobinuria. This is obviously greater than the approximate 600 mg of plasma hemoglobin (per unit transfused blood) which would be present if one assumed hemolysis at the highest rate in the 70°C saline admixture using 35 day old erythrocytes.
Clinical application of blood warming wi h the present invention would require the availability of heated containers of normal saline solution. Methods for heating saline solution containers include microwave ovens or dry oven/incubator. While use of microwave ovens to warm saline solution is an acceptable method, it introduces an additional time delay prior to beginning transfusion. Owing to changes in saline concentration over time, long term water bath incubation is not recommended by at least certain of the manufacturers of the saline solution. Blanket warmers to not offer close enough temperature requlation (+/- 5.5°C) to be acceptable for application. At present, the most acceptable instrument for saline solution heating and storage is a microbiological incubator. This type of unit provides close temperature regulation (+/- 0.5°C) and is able to achieve the temperatures utilized herein.
The materials for admixture blood warming are already used in transfusion therapy. These include saline solution bags, large bore transfusion sets, Y-type transfusion sets and plasma transfer sets. For transfer o the saline solution during the admixture process, pressure can be applied by hand or by using a standard pressure cuff. Optimal control of the mixture temperature will be obtained by ensuring a 1:1 saline/erythrocyte mixture. This may necessitate either standardization of erythrocyt volumes or weighing of individual units and admixing with an equal amount of heated saline solution. Assessment of mixture temperature can be achieved using external temperature sensors.
Testing, as described in further detail below, was performed to determine the effect of admixture using saline solution at temperatures of 60°C, 70°C and 80°C. These tests evaluated subtle membrane effects as assessed by erythrocyte osmotic fragility testing.
Units of red blood cells were prepared from blo collected in citrate-phosphate-dextrose-adenine solution (CPDA-1) and stored in standard blood containers at 4°C until used. The average hematocrit of these units was 75 At the time of the admixture tests, the units were divide into paired aliquotes of 100 to 125 g. each. All admixtu tests and controls were done on day 35 following blood donation. For admixture tests, saline solution bags (suc as travenol 0.9% NaCl ) were weighted to within one gram o the erythrocyte aliquotes (100 to 125 g.). The saline solution bags were then water bath heated to either 60, 7 or 80°C. Temperature was determined using an in-bag prob (such as Hewlett-Packard #2802A) . Bags of erythrocytes, 6-10°C were gently agitated by hand while heated saline w rapidly added under hand-generated pressure via a plasma transfer set. This was accomplished by squeezing the saline solution bag with a gloved hand. Agitation consisted of a rapid (once per second) rocking of the blo bag. Saline was transferred within 15 seconds; agitation continued for 1 minute. The mixture temperature was measured by a probe in the bag and samples were obtained for osmotic fragility tests. The mixture was then centrifuged and the resultant supernatant assessed for plasma hemoglobin. Five trials were carried out at each temperature with a control for each trial and a total of 15 units of blood were used.
The controls consisted of an in-bag admixture of 100-125 g. aliquotes of erythrocytes (at 6-10°C) with a equal amount of cold saline (at 6-10°C). Osmotic fragilit of the resultant mixture was determined utilizing incubation in ten concentrations of NaCl (0-0.85%) followed by centrifrigation (lOOOg for 10 minutes) and colormetric reading at 540 nm. Plasma hemoglobin concentrations were determined following centrifugation of the admixture product (1000 g for 10 minutes). Colormetric absorption o the supernatant was assessed at 560, 575 and 590 nm. The technique was standardized using known concentrations of hemoglobin. The mean temperatures of the resultant erythrocyte—saline mixtures for the five trials at each of the saline temperatures (60, 70 and 80°C) were 30.9, 37.5 and 42.6°C, respectively.
Table 1 below shows the Plasma hemoglobin and potassium values for control and admixture trials.
TABLE 1
Saline Temp Plasma Hgb (mg%) Potassium (meg/1)
(°C) n control trial control trial
60 282.0 242.1* 16.6 16.2*
70 184.7 158.7* 11.7 10.6*
80 131.3 1244.0** 12.2 14.4**
**significant increase over control (p < .01) *no significant increase over control values No significant elevation of plasma hemoglobin or potassiu occurred in trials utilizing 60-70°C saline. Admixture with 80°C saline solution resulted in significant elevatio of plasma hemoglobin and potassium (p < .01, paired t-test) .
Figures 1 to 3 show average osmotic fragility curves for controls and admixture trials at each of the three saline solution temperatures. No significant difference was found between control and trials at any concentration of NaCl (0-0.85%) for saline solution temperatures of 60°C and 70°C. Trials using 80° saline solution resulted in significantly increased osmotic fragility at multiple levels of NaCl concentration (p < .01, paired t-test). Turning now to Figure 4, there is shown a blood warmer device 10 for effecting a rapid mechanical mixing o blood products in a container 12 at storage temperature (4°C) with a heated saline solution in container 14. As used herein, the term blood products is intended to includ whole blood, packed cells, erythrocytes, hemoglobin solutions, synthesized alterations of hemoglobin or blood substitutes. Container 12 may be of the standard bag type used in the industry for collecting and storing erythrocytes (red blood cells). It may be suspended from suitably configured hook 16 supported by sidewall 18. The container includes a discharge tube 20 extending from the lower end in penetrable engagement with a base 22. Flow control means 24 regulates the flow through tube 20. Container 14 may be an industry standard bag type for saline solution. Container 14 is suspended by a hook 30 supported by sidewall 32. Container 14 also includes a tube 34 for discharging fluid out of the container and flo control means 36 regulates the flow through the tube.
A discharge conduit 40 is in fluid communication with tubes 20, 34 through a multi-port valve 42, which valve can accommodate flow between tubes 20 and 34 or between tube 34 and conduit 40 through manipulation of a pointer/knob 44, which may be substituted by semi-automatic or automatic flow control/regulation devices. A flow control means 46 regulates flow through conduit 40. It is to be understood that any or all of flow control means 24, 36 and 46 may include any type of functionally related devices, such as centrifugal or roller pump assemblies for drawing or forcing fluid flow.
A partition 50 extends upwardly from base 22 for supporting means for expressing fluid from container 14 and for independently or simultaneously expressing fluid from container 12. Means for rapidly mechanically agitating the contents of container 12 may also be supported upon partition 50. In the embodiment illustrated, air bags, such as air bags 52, 54, are supported upon partition 50 adjacent container 12. A source of air under pressure, including pressure regulating means, (not illustrated) is connected to inlet conduit 56 of air bag 52 and inlet conduit 58 of air bag 54. Upon inflation of either or both of air bags 52, 54, they will expand to bear against container 12 and urge evacuation of container 12 commensurate with the air bag pressure and degree of flow restriction presented by flow control means 24 and discharge tube 20. Control means, not illustrated, may be employed to sequentially inflate/deflate air bags 52, 54 to urge rapid movement of the liquid within container 12 in response to the alternating locations of application of pressure.
Partition 50 may also be employed to support a pair of air bags 60, 62 adjacent container 14. A source of air pressure and pressure regulating means (not illustrated) may be employed to regulate air flow into and out of the air bags through inlet conduits 64, 66. Expansion through inflation of either or both air bags 60, 62 will exert pressure against container 14 to urge expressing of any fluid contained therein through tube 34. If air bags 60, 62 are alternatively inflated/deflated, the resulting alternating pressure forces acting upon container 14 will have the effect of repetitively relocating the fluid within container 14. Such relocation will agitate the fluid and produce rapid mixing if the fluid is not already homogenous in content or temperature. Referring jointly to Figures 4, 5a, 5b and 6, t operation of blood warmer device 10 will be described. Container 14, containing heated saline solution to be mix with blood products and to be infused by transfusion and a temperature in the range of 50 to less than 80°C, is suspended from hook 30 adjacent sidewall 32. Container 1 containing blood products to be infused by transfusion an at a temperature of approximately 4°C, is suspended from hook 16 adjacent sidewall 18. Upon inflation of air bags 60, 62, pressure will be brought to bear against containe 14 to express the contents thereof. Upon opening
(operation) of flow control means 36, the saline solution will flow through tube 34 to ulti port valve 42, as indicated by the arrow in Figure 5a. Assuming that knob has been actuated to interconnect tube 34 with tube 20, a depicted in Figure 5a and that flow control means 46 is closed, the saline solution will flow through valve 42, tube 20 and into container 12. Simultaneously, air bags and 54 may be inflated/deflated alternately to exert, at alternate locations, pressure upon container 12. Such induced alternating pressure forces at different locations will result in mechanically forcing any fluid within container 14 to be rapidly agitated. Thereby, the saline solution flowing into container 12 through tube 20 is rapidly admixed with the blood products. Upon evacuation of container 14, the admixing within container 14 may continue for a period of time or may be terminated.
The admixture in container 14 is discharged therefrom through' tube 20 and multi port valve 42 after knob 40 has been turned to provide flow into conduit 40, a depicted in Figure 5b. The flow through conduit 40 may be regulated by flow control means 46. From conduit 40, the admixture flows to and is injected by conventional transfusion equipment. From the above-description, it will be evident that air bags 52, 54 impose mechanical forces upon container 14 to agitate rapidly any fluid within the container, which agitation results in mixing of any fluids therein. The degree of force to be applied and hence severity of agitation is a function of the pressures exerted by the air bags.
Rapid mechanical mixing may also be effected by the present invention through multi port valve 42. In the configuration of valve 42 depicted in Figure 6, flow from each of tubes 20, 34 into conduit 40 is possible. At intersection 70 of the flows, particularly if the flow rates are significant, an admixing of the fluids will occur. Through such admixing, a temperature equilibrium of the admixture will come about relatively rapidly upon flow of the admixture into conduit 40. The force exerted by the fluids upon one another at intersection 70 will be a function of the completeness of the admixture. It will be immediately apparent that the admixture which occurs at intersection 70 will be sufficiently brief to preclude incubation of any blood products at a temperature higher than 45°C for any significant time period if the initial temperature of the blood products is 4-10°C and the temperature of the saline solution is 50°C to less than 80°C. It is to be understood that the above described function of intersection 70 could be accomplished by a mixing chamber of simple or complex design and capability.
Figure 7 illustrates a variant 80 of blood warmer device 10 illustrated in Figure 4. To the extent the device shown in Figure 7 is equivalent to the device shown in Figure 4, the same reference numerals will be employed. The flexible container for saline solution shown in Figure 4 has been replaced 'with a rigid sleeve and piston unit 82. A bottom 84 extends across sleeve 86 to develop a containe for retaining a fluid, such as a saline solution to be expressed. Conduit 34 extends into bottom 84 and is in fluid communication with the contents of the unit. A translatable piston 88 is actuatable by a connecting rod plunger 90 bearing against a receiving cup 92. A plurali of linkages and pivot mechanisms, as depicted by numerals 94, 96, respectively, provide rectilinear translation to the plunger. Although not so depicted in Figure 7, it is to be understood that closed compartment 98 may be employ to house motive means for translating plunger 90 through linkages 94, 96. Other means for imparting translatory movement to piston 88 may also be employed. The sleeve and piston unit depicted in Figure 7 illustrates the unit to be essentially rectangular in cro section. Under certain circumstances, such configuration may not be preferred. Accordingly, a more conventional cylindrical sleeve and piston unit 100 is depicted in Figure 8. Herein, sleeve 102 is terminated at its lower end by a bottom 104 having tube 112 connected thereto to convey a fluid expressed from the unit. A disc like pist 106 is in sealed engagement with the interior surface wit sleeve 102 through 0-ring 108, or the like. A rod 110, connected to a source of power (not illustrated) imparts a downward force upon the piston, which downward force discharges the fluid from within the compartment defined b piston 106 and sleeve 102 through tube 112. It is to be understood that sidewall 32 and partition 50 (see Figure 7 can be modified to receive and retain unit 100 and that th latter is capable of functioning in the manner of unit 82. It is to be understood that collapsible bags of saline solution can be placed within either of units 82, 100 to b expressed by force of the respective piston; means must be adapted to place discharge tube 34 in fluid communication with the bag.
If a saline solution is housed as shown in Figur 4 or in either of sleeve and piston units 82, 100, sidewal 32 and partition 50 may be adapted to support heating elements for warming or for maintaining the temperature of the saline solution within the respective container. Thes heating units are represented by dashed lines identified b reference numerals 114 and 116. Similarly, a heating unit 118 may be formed adjacent container 12 to maintain the contents of container 12 at or near body temperature. Appropriate heat/temperature limits may be incorporated in heating units 114, 116 and 118.
It is to be understood that the respective saline container or sleeve and piston units may have a capacity equivalent to that of blood product container 12 with the admixture to be performed at valve 42 or in container 12. Alternatively, container 14, units 82, 100 may each have a capacity which is a multiple of the capacity of container 12 to permit development of an admixture in each of several blood products containers before refill or replacement of container 14, units 82, 100. In operation and assuming that container 12 has a substantial free volume, the transfer from container 14, unit 82 or 100 to container 12 is the expressing of saline solution into the container. Subsequent mixing within the container may be effected by alternate inflation/deflation of air bags 52, 54. Final expression of the admixture fro container 12 may be effected through valve 42 into conduit 40. It is to be understood that other procedural variations may exist for effecting rapid, forced and mechanical mixing of the blood products and the saline solution.
Several alternative procedures for agitating the admixture may be undertaken. In example, the admixture within container 12 may be drawn into unit 82 through a combination of retraction of plunger 90 and inflation of air bags 52, 54 acting to compress container 12 while valv 42 is in the position depicted in Figure 5a. At or some point, the movement of plunger 90 may be reversed to force piston 88 to express the admixture through tubes 34 and 20 into container 12. This cycle may be repeated one or more times before the resulting admixture is discharged via valve 42 through conduit 40. While the principles of the invention have now been made clear an illustrative embodiment, there will be immediately obvious to those skilled in the art many modifications of structure, arrangement, proportions, elements, materials and components, used in the practice the invention which are particularly adapted for specific environment and operating requirements without departing from those principles.

Claims

CLAIMS :
1. Apparatus for rapidly warming chilled and stored blood products, such as erythrocytes, from a temperature in the range of 4°C to 10°C to a temperature in the range of 32°C to 39°C without hemolysis, said apparatus comprising in combination:
(a) a first container for containing a quantity of the blood products;
(b) a quantity of heated saline solution at a temperature in the range of 45°C to less than 80°C;
(c) a second container for said saline solution;
(d) means for admixing the blood products and said saline solution to effect a heat transfer from said saline solution to the bloody products; and
(e) means for conveying the admixture to a point of use.
2. The apparatus as set forth in Claim 1 including first means for evacuating said first container and second means for evacuating said second container.
3. The apparatus as set forth in Claim 2 wherein each of said first and second evacuating means comprises means for pressurizing the contents of each of said first and second containers, respectively.
4. The apparatus as set forth in Claim 3 wherein said press irizing means includes means for periodically applying pressure to consecutively different locations upon one of said first and second containers.
5. The apparatus as set forth in Claim 1 including means for transferring heat to said saline solution disposed in said second container.
6. The apparatus as set forth in Claim 1 wherein said admixing means includes means for developing the admixture at the rate of at least 250 ml/minute within a temperature in the range of 32°C to 39°C.
7, The apparatus as set forth in Claim 6 wherein said admixing means includes means for developing the admixture at a rate greater than 500 ml/minute within temperature in the range of 32°C to 39°C.
8. The apparatus as set forth in Claim 1 wherein said admixing means includes means for expressing said first and second containers and wherein said expressing means comprises at least one repetitively inflatable and deflatable bag associated with one of said first and second containers.
9. The apparatus as set forth in Claim 1 wherein said first and second containers iriclude equal quantities of erythrocytes and said saline solution, respectively, and wherein said admixing means admixes the erythrocytes and said saline solution in essentially equal proportions.
10. A method carried out with the structure recited in any of Claims 1, 3, 6, 7, 8 or 9 for warming chilled blood products, such as erythrocytes, to prevent hemolysis during warming and to prevent hypothermia upon transfusion of same.
PCT/US1988/000255 1987-03-16 1988-02-01 Apparatus and method for admixture blood warming WO1988006896A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/026,478 US4808159A (en) 1987-03-16 1987-03-16 Apparatus and method for admixture blood warming
US026,478 1993-03-04

Publications (1)

Publication Number Publication Date
WO1988006896A1 true WO1988006896A1 (en) 1988-09-22

Family

ID=21832062

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/000255 WO1988006896A1 (en) 1987-03-16 1988-02-01 Apparatus and method for admixture blood warming

Country Status (4)

Country Link
US (1) US4808159A (en)
EP (1) EP0346351A1 (en)
AU (1) AU1228188A (en)
WO (1) WO1988006896A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726080A3 (en) * 1995-02-02 1998-03-11 Barkey Volker Device for tempering infusion bags
WO2014181158A1 (en) * 2013-05-07 2014-11-13 Biosafe S.A. Mixing system for mixing biological specimens with additives
CN109821094A (en) * 2019-03-08 2019-05-31 河北华蓝医疗器械有限公司 A kind of medical treatment blood transfusion and infusion pressurization instrument and its working method

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5125900A (en) * 1990-09-24 1992-06-30 Teves Leonides Y Device for heating and pressurizing fluid-filled containers
US5242434A (en) * 1990-12-20 1993-09-07 Terry William M Medical waste handling system
US5295964A (en) * 1991-10-02 1994-03-22 Gauthier Robert T Holder and warmer for IV solution containers
US5842033A (en) * 1992-06-30 1998-11-24 Discovision Associates Padding apparatus for passing an arbitrary number of bits through a buffer in a pipeline system
US6079009A (en) * 1992-06-30 2000-06-20 Discovision Associates Coding standard token in a system compromising a plurality of pipeline stages
US6263422B1 (en) * 1992-06-30 2001-07-17 Discovision Associates Pipeline processing machine with interactive stages operable in response to tokens and system and methods relating thereto
US5391142A (en) * 1992-07-29 1995-02-21 Organetics, Ltd. Apparatus and method for the extracorporeal treatment of the blood of a patient having a medical condition
US5354277A (en) * 1992-09-04 1994-10-11 Biocontrol Technology, Inc. Specialized perfusion protocol for whole-body hyperthermia
US5476444A (en) * 1992-09-04 1995-12-19 Idt, Inc. Specialized perfusion protocol for whole-body hyperthermia
US5807359A (en) 1993-06-08 1998-09-15 Bemis Manufacturing Company Medical suction system
US5368569A (en) * 1993-08-18 1994-11-29 Sanese Medical Corporation Irrigation system for preventing contamination and reducing the risk of patient hypothermia
US5588959A (en) * 1994-08-09 1996-12-31 University Of Washington Hemodialysis recirculation measuring method
US6244311B1 (en) 1994-12-29 2001-06-12 Bemis Manufacturing Company Method and apparatus for removing and disposing of body fluids
US6358232B1 (en) 1994-12-29 2002-03-19 Bemis Manufacturing Company Method and apparatus for removing and disposing of body fluids
US5741238A (en) * 1995-03-02 1998-04-21 Steris Corporation Medical and biological fluid collection and disposal system
US5776118A (en) * 1995-12-13 1998-07-07 Steris Corporation Medical and biological fluid collection and disposal system
US6824528B1 (en) 1997-03-03 2004-11-30 Medical Solutions, Inc. Method and apparatus for pressure infusion and temperature control of infused liquids
US7090658B2 (en) * 1997-03-03 2006-08-15 Medical Solutions, Inc. Temperature sensing device for selectively measuring temperature at desired locations along an intravenous fluid line
US7041941B2 (en) * 1997-04-07 2006-05-09 Patented Medical Solutions, Llc Medical item thermal treatment systems and method of monitoring medical items for compliance with prescribed requirements
US6467953B1 (en) 1999-03-30 2002-10-22 Medical Solutions, Inc. Method and apparatus for monitoring temperature of intravenously delivered fluids and other medical items
US6660974B2 (en) * 1997-04-07 2003-12-09 Medical Solutions, Inc. Warming system and method for heating various items utilized in surgical procedures
US7276675B2 (en) * 1997-04-07 2007-10-02 Patented Medical Solutions, Llc Medical item thermal treatment systems and method of monitoring medical items for compliance with prescribed requirements
WO2001072350A1 (en) 2000-03-28 2001-10-04 Bemis Manufacturing Company Medical suction apparatus and methods for draining same
US7585292B2 (en) * 2000-03-28 2009-09-08 Bemis Manufacturing Company Medical suction apparatus and draining of same
US7674248B2 (en) * 2000-03-28 2010-03-09 Bemis Manufacturing Company Medical suction apparatus and methods for draining same
US6672477B2 (en) 2001-01-12 2004-01-06 Bemis Manufacturing Company Method and apparatus for disposing of bodily fluids from a container
US7238171B2 (en) * 2001-03-12 2007-07-03 Medical Solutions, Inc. Method and apparatus for controlling pressurized infusion and temperature of infused liquids
US7031602B2 (en) * 2001-03-12 2006-04-18 Patented Medical Solutions, Llc Method and apparatus for controlling temperature of infused liquids
US7722839B2 (en) * 2001-10-11 2010-05-25 Cytotherm, L.P. Apparatus and method for thawing biological materials
US8226605B2 (en) 2001-12-17 2012-07-24 Medical Solutions, Inc. Method and apparatus for heating solutions within intravenous lines to desired temperatures during infusion
JP4101511B2 (en) * 2001-12-27 2008-06-18 株式会社半導体エネルギー研究所 Light emitting device and manufacturing method thereof
US6837610B2 (en) * 2002-09-27 2005-01-04 Ilc Dover Lpp Bioprocess container, bioprocess container mixing device and method of use thereof
US7377686B2 (en) * 2003-09-04 2008-05-27 Millipore Corporation Disposable mixing system
US20050101922A1 (en) * 2003-11-07 2005-05-12 Bemis Manufacturing Company Suction canister and drainage of same
US7611504B1 (en) 2004-03-09 2009-11-03 Patented Medical Solutions Llc Method and apparatus for facilitating injection of medication into an intravenous fluid line while maintaining sterility of infused fluids
US8012416B2 (en) * 2005-08-30 2011-09-06 Cytotherm, L.P. Thawing biological material using a sealed liquid bladder
US7740611B2 (en) 2005-10-27 2010-06-22 Patented Medical Solutions, Llc Method and apparatus to indicate prior use of a medical item
US8487738B2 (en) * 2006-03-20 2013-07-16 Medical Solutions, Inc. Method and apparatus for securely storing medical items within a thermal treatment system
US8226293B2 (en) 2007-02-22 2012-07-24 Medical Solutions, Inc. Method and apparatus for measurement and control of temperature for infused liquids
US20140228755A1 (en) * 2009-12-26 2014-08-14 Athena Gtx, Inc. Fluid Balance Monitoring System with Fluid Infusion Pump for Medical Treatment
US9211381B2 (en) 2012-01-20 2015-12-15 Medical Solutions, Inc. Method and apparatus for controlling temperature of medical liquids
BR112015012611B8 (en) * 2012-12-03 2020-09-24 Ge Healthcare Bio Sciences Corp heat exchange module for use in a chemical, pharmaceutical or biological reactor system
US9656029B2 (en) 2013-02-15 2017-05-23 Medical Solutions, Inc. Plural medical item warming system and method for warming a plurality of medical items to desired temperatures
CN104096279A (en) * 2013-04-02 2014-10-15 泛玉健康科技事业股份有限公司 Liquid medicine warming and squeezing device
US10921021B2 (en) * 2016-03-23 2021-02-16 Wwt Technischer Geraetebau Gmbh Modular blood warmer
US11484633B1 (en) * 2022-04-05 2022-11-01 Archemedic Solutions, Llc Multi-stage blood warming system that enables field delivery of heated blood

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3982534A (en) * 1975-01-10 1976-09-28 Buckman Thomas P Intravenous administration system
WO1987001946A1 (en) * 1985-09-30 1987-04-09 Regents Of The University Of Minnesota Appratus and method for rapid infusion of circulatory supportive fluids

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US771600A (en) * 1903-08-17 1904-10-04 William J Bauer Douche apparatus.
US1161401A (en) * 1913-10-31 1915-11-23 Meinecke & Company Combined water bottle and heater for fountain-syringes.
US2396043A (en) * 1942-03-23 1946-03-05 E C D Ltd Dispensing apparatus
US2910981A (en) * 1954-01-08 1959-11-03 Volney C Wilson Replacement blood transfusion apparatus
US3044465A (en) * 1958-05-08 1962-07-17 Andermac Mixing and dispensing apparatus
US3572338A (en) * 1968-02-27 1971-03-23 Leo E Murray Jr Mixing and delivery apparatus
US4249923A (en) * 1979-07-10 1981-02-10 Walda Kim L Cardioplegic fluid refrigeration and delivery system
US4416280A (en) * 1980-04-07 1983-11-22 Minnesota Mining And Manufacturing Company Cardioplegia delivery system
US4430078A (en) * 1981-04-24 1984-02-07 Sprague Leland L Blood infusion pump
US4531941A (en) * 1982-09-08 1985-07-30 Henry Ford Hospital Method and apparatus for administering blood
US4539005A (en) * 1983-10-24 1985-09-03 Greenblatt Gordon M Blood infusion apparatus and method
US4623333A (en) * 1984-09-28 1986-11-18 Fried Steven J Fried-Grant rapid solution administration set with integral heat exchanger
US4678460A (en) * 1985-02-11 1987-07-07 Rosner Mark S Portable rapid massive parenteral fluid warming and infusion apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3982534A (en) * 1975-01-10 1976-09-28 Buckman Thomas P Intravenous administration system
WO1987001946A1 (en) * 1985-09-30 1987-04-09 Regents Of The University Of Minnesota Appratus and method for rapid infusion of circulatory supportive fluids

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726080A3 (en) * 1995-02-02 1998-03-11 Barkey Volker Device for tempering infusion bags
WO2014181158A1 (en) * 2013-05-07 2014-11-13 Biosafe S.A. Mixing system for mixing biological specimens with additives
CN105263611A (en) * 2013-05-07 2016-01-20 生物安全股份有限公司 Mixing system for mixing biological specimens with additives
US20160106624A1 (en) * 2013-05-07 2016-04-21 Biosafe S.A. Mixing System for Mixing Biological Specimens with Additives
JP2016518845A (en) * 2013-05-07 2016-06-30 ビオセフ エス・アー Mixing system for mixing biological specimens with additives
RU2637220C2 (en) * 2013-05-07 2017-12-01 Биосейф С.А. Mixing system for biological samples mixing with additives
CN105263611B (en) * 2013-05-07 2018-05-08 生物安全股份有限公司 Hybrid system for mixed biologic sample and additive
US11077020B2 (en) * 2013-05-07 2021-08-03 Biosafe S.A. Fluid processing based on inflatable bags, mixing system, and method of use thereof
US20210308011A1 (en) * 2013-05-07 2021-10-07 Biosafe S.A. Fluid Processing Based on Inflatable Bags, Mixing System, and Method of Use Thereof
US11918541B2 (en) 2013-05-07 2024-03-05 Biosafe S.A. Fluid processing based on inflatable bags, mixing system, and method of use thereof
CN109821094A (en) * 2019-03-08 2019-05-31 河北华蓝医疗器械有限公司 A kind of medical treatment blood transfusion and infusion pressurization instrument and its working method
CN109821094B (en) * 2019-03-08 2021-03-30 河北华蓝医疗器械有限公司 Medical treatment blood transfusion and infusion are with pressurization appearance and working method thereof

Also Published As

Publication number Publication date
EP0346351A1 (en) 1989-12-20
US4808159A (en) 1989-02-28
AU1228188A (en) 1988-10-10

Similar Documents

Publication Publication Date Title
US4808159A (en) Apparatus and method for admixture blood warming
US4560472A (en) Peritoneal dialysis apparatus
US4539005A (en) Blood infusion apparatus and method
US6824524B1 (en) Tubing for the extracorporal purification of the blood and use thereof
AU720741B2 (en) System and method for providing sterile fluids for admixed solutions in automated peritoneal dialysis
EP0234713B1 (en) Unitary heat exchanger and debubbler for a liquid
FI115955B (en) Device for performing peritoneal dialysis
US3640283A (en) Disposable blood-warming container
US2847007A (en) Fluid handling unit and apparatus
EP0428009A1 (en) A method for the preparation of a sterile dialysis fluid for medical use or a similar physiologically acceptable sterile fluid
USRE26006E (en) Transfusion set
JPH0257258A (en) Sterillization system for storing blood
Rune Acid-base parameters of duodenal contents in man
JPH08507244A (en) Blood storage container and method of use
JPH0475016B2 (en)
US4705508A (en) Apparatus and method for rapid infusion of circulatory supportive fluids
JP2022180392A (en) Device for preserving blood products and cellular cultures in a gas medium under pressure
JPH0576595A (en) Device and method for continuous type peritoneal dialysis
US3682172A (en) Parabiotic dialysis apparatus
Arens et al. Danger of overwarming blood by microwave
US3058464A (en) Oxygenator
AU2003300951A8 (en) Fluid treatment method, apparatus and system
US3276589A (en) Apparatus for maintenance and treatment of blood in vitro
US3171475A (en) Apparatus for blood handling
Linko et al. Erythrocyte damage caused by the Haemotherm® microwave blood warmer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988901392

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988901392

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988901392

Country of ref document: EP